Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury
about
The Role of Galectin-3 in the KidneysGalectins in epithelial functionsHuman galectin-2 interacts with carbohydrates and peptides non-classically: new insight from X-ray crystallography and hemagglutinationClinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentPlanar cell polarity and the kidney.Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis.Galectin-3 Inhibition Is Associated with Neuropathic Pain Attenuation after Peripheral Nerve InjuryGalectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D StudiesGalectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal DamagePlasma galectin 3 and heart failure risk in the Physicians' Health Study.Vascular Endothelial Growth Factor C for Polycystic Kidney DiseasesGalectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction.Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and GalactomannansElevated galectin-3 precedes the development of CKDGalectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.Loss of endogenous thymosin β4 accelerates glomerular disease.Galectin-3: a modifiable risk factor in heart failure.Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes.Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.Beneficial Role of Citrus Fruit Polyphenols Against Hepatic Dysfunctions: A Review.Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy.Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Synergistic Antioxidant and Anti-Inflammatory Effects between Modified Citrus Pectin and Honokiol.Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage.Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.Controlling the Degree of Esterification of Citrus Pectin for Demanding Applications by Selection of the Source.Biomass Derived and Biomass Inspired Polymers in Pharmaceutical ApplicationsOxidative DNA damage induced by ROS-modulating agents with the ability to target DNA: A comparison of the biological characteristics of citrus pectin and apple pectin
P2860
Q26752754-F5A3C2C6-B3BF-4E77-AFEE-F30E0290302AQ27000800-26478EAA-5BE7-4E7B-92B5-5F9813718314Q27727738-6FBEF4B0-5DC7-4742-B8F9-986BFE577305Q33754895-626D0280-B40D-48B4-9C78-C58191B4F0CEQ33807051-285BD227-A332-4B27-9ECF-FEF352CD1D0CQ33982118-78636F6E-DA07-457C-9E0D-E078BA06CB09Q35070734-EA582F76-A6FB-4C8A-A15D-87B33FB7C7C1Q35922361-C8278FA6-EBB1-4592-976C-EDA41C7B9B48Q36003071-201DD282-8FCC-4EF1-90AB-34B2169664E8Q36187612-157E5FF1-D4D3-4354-A645-11C9614CD56DQ36283028-F4FA76B2-F160-412D-A52C-ECD950C61EF5Q36417877-02522321-4825-43D2-9B35-EA7FC5E56B86Q36439679-348DC8FB-5A8B-4849-BF3A-48C48614C47AQ36627699-1C809C0C-FB58-492E-AB47-691982551522Q37065931-867D3EF7-AE44-437E-A199-0381C7DA8037Q37119904-7EFF35A3-9A5D-4B3B-B879-019770F70D17Q37125501-AEC7E756-6A00-43F6-8A73-1B572C38D9BFQ37354989-971FD321-CEFE-408C-B1A5-7B4E81181259Q38208784-AFB83855-1031-40A5-B462-E30C61C1CCE6Q38426618-902F22C0-50E8-4632-B435-C8A46886900EQ39191329-0CD381BC-E5C7-4D3A-83B2-172C83B45299Q39391427-191198B8-3016-4C26-A1B1-3451CF968217Q40060474-AF1EA4F7-F51C-4B63-A765-E86CBA4E43ECQ40108985-A53F6688-64E4-4928-88A6-63C025D01FC8Q41695164-CE214322-FDC2-4FAC-9AFF-7455F61EAB1DQ47333014-E09D46E2-8D09-4034-BF90-068B23908E9CQ47653100-37570860-F723-4220-9C1B-05B2BFF4A5A7Q48159180-CF746B8F-3C37-40DD-91F5-80A4147961B0Q48357935-CD80FA32-1BDA-41EB-9BC8-0520F9898FA2Q50133781-F0403B0E-F1D4-43BB-9C44-8C13A1D468AFQ53138646-4C78423B-DE29-4C2C-A16D-2398CAC90CF9Q55657396-1296F984-AEE1-4E38-9374-43ED3575B4B5Q58484641-41B4B9FA-5437-4D32-B5F2-80A1B2C097A0Q58734051-E7CBFED9-952F-40D2-A29F-6601897429C8
P2860
Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modified citrus pectin reduces ...... perimental acute kidney injury
@ast
Modified citrus pectin reduces ...... perimental acute kidney injury
@en
type
label
Modified citrus pectin reduces ...... perimental acute kidney injury
@ast
Modified citrus pectin reduces ...... perimental acute kidney injury
@en
prefLabel
Modified citrus pectin reduces ...... perimental acute kidney injury
@ast
Modified citrus pectin reduces ...... perimental acute kidney injury
@en
P2093
P2860
P1433
P1476
Modified citrus pectin reduces ...... perimental acute kidney injury
@en
P2093
David A Long
Karen L Price
Maria Kolatsi-Joannou
Paul J Winyard
P2860
P304
P356
10.1371/JOURNAL.PONE.0018683
P407
P577
2011-04-08T00:00:00Z